Budget Impact Analysis Of The Introduction Of Saxagliptin/Metformin Extended-Release (Xr) In The Treatment Of Type-2 Diabetes In Chile
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.796
https://www.valueinhealthjournal.com/article/S1098-3015(13)00867-X/fulltext
Section Title :
Diabetes/Endocrine Disorders
Section Order :
335
First Page :
A159
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00867-X&doi=10.1016/j.jval.2013.03.796